Panazee develops an ultra-high resolution biomarker platform for research, point-of-care diagnostics, and home testing, enabling precise health assessments. This technology addresses the need for accurate and accessible health monitoring solutions, enhancing patient care and research capabilities.
Funding
Funding not disclosed
Founders
Product
Problem
Current biomarker analysis methods often lack the sensitivity and resolution needed for early disease detection and precise health monitoring. Traditional lab-based tests can be time-consuming, expensive, and inaccessible for point-of-care or home use, hindering timely interventions and personalized healthcare.
Solution
Panazee is developing a novel biomarker platform that enables ultra-high resolution analysis for research, point-of-care diagnostics, and home testing. This technology aims to provide more accurate and accessible health assessments, facilitating earlier disease detection and improved patient care. By enhancing the precision of biomarker measurements, Panazee's platform seeks to empower researchers and clinicians with better insights into disease mechanisms and treatment responses. The platform's potential for point-of-care and home testing could also expand access to timely health monitoring, particularly for individuals in remote locations or with limited mobility.
Target Audience
The primary target audience includes researchers, clinicians, and healthcare providers seeking more accurate and accessible biomarker analysis tools, as well as individuals interested in at-home health monitoring solutions.
Features
- Ultra-high resolution biomarker detection technology
- Potential applications in research, point-of-care diagnostics, and home testing